These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1680125)

  • 1. Benzodiazepine hypnotics: sorting the pharmacokinetic facts.
    Greenblatt DJ
    J Clin Psychiatry; 1991 Sep; 52 Suppl():4-10. PubMed ID: 1680125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of pharmacologic effects and toxicity of benzodiazepine hypnotics: role of lipophilicity and plasma elimination rates.
    Arnold J
    J Clin Psychiatry; 1991 Sep; 52 Suppl():11-4. PubMed ID: 1654317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criteria for selection of appropriate benzodiazepine hypnotic therapy.
    Mendels J
    J Clin Psychiatry; 1991 Sep; 52 Suppl():42-6. PubMed ID: 1680126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies.
    Soldatos CR; Dikeos DG; Whitehead A
    Int Clin Psychopharmacol; 1999 Sep; 14(5):287-303. PubMed ID: 10529072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quazepam and flurazepam: differential pharmacokinetic and pharmacodynamic characteristics.
    Hilbert JM; Battista D
    J Clin Psychiatry; 1991 Sep; 52 Suppl():21-6. PubMed ID: 1680120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quazepam: hypnotic efficacy and side effects.
    Kales A
    Pharmacotherapy; 1990; 10(1):1-10; discussion 10-2. PubMed ID: 1969151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Choosing the correct benzodiazepine: mechanism of action and pharmacokinetics].
    Vinkers CH; Tijdink JK; Luykx JJ; Vis R
    Ned Tijdschr Geneeskd; 2012; 155(35):A4900. PubMed ID: 22929751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The classification and mechanism of the hypnotics].
    Hashizume Y
    Nihon Rinsho; 1998 Feb; 56(2):510-4. PubMed ID: 9503860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma concentrations and clinical activity of benzodiazepines].
    Boyer P
    Encephale; 1983; 9(4 Suppl 2):59B-65B. PubMed ID: 6144531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and drug interactions of the sedative hypnotics.
    Wang JS; DeVane CL
    Psychopharmacol Bull; 2003; 37(1):10-29. PubMed ID: 14561946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction: pharmacokinetic considerations. Benzodiazepine hypnotics: the interface of basic and clinical science.
    Greenblatt DJ
    J Clin Psychiatry; 1991 Sep; 52 Suppl():3. PubMed ID: 1680122
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics, pharmacodynamics, and treatment issues of benzodiazepines: alprazolam, adinazolam, and clonazepam.
    DeVane CL; Ware MR; Lydiard RB
    Psychopharmacol Bull; 1991; 27(4):463-73. PubMed ID: 1687613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and the sedative effect of midazolam.
    Kanto J; Allonen H
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):460-3. PubMed ID: 6138314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of the effects of benzodiazepines. Pharmacodynamic studies in man.
    Nicholson AN
    Encephale; 1983; 9(4 Suppl 2):81B-86B. PubMed ID: 6144534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate use of benzodiazepines in insomnia: clinical update.
    Hishikawa Y
    J Clin Psychiatry; 1991 Jul; 52 Suppl():10-3. PubMed ID: 2071565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recommendations for the diagnosis and therapy of insomnia. German Society of Sleep Research and Sleep Medicine DGSM].
    Clarenbach P; Steinberg R; Weess HG; Berger M
    Nervenarzt; 1995 Oct; 66(10):723-9. PubMed ID: 7501087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of benzodiazepines. Short-acting versus long-acting.
    Breimer DD; Jochemsen R; von Albert HH
    Arzneimittelforschung; 1980; 30(5a):875-81. PubMed ID: 6106488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of benzodiazepine and non-benzodiazepine anxiolytic-hypnotic drugs: an analytical point of view.
    Mandrioli R; Mercolini L; Raggi MA
    Curr Drug Metab; 2010 Nov; 11(9):815-29. PubMed ID: 21189133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of anxiolytics and hypnotics: benzodiazepines, buspirone, zoplicone, and zolpidem.
    Chouinard G; Lefko-Singh K; Teboul E
    Cell Mol Neurobiol; 1999 Aug; 19(4):533-52. PubMed ID: 10379424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit.
    Barr J; Donner A
    Crit Care Clin; 1995 Oct; 11(4):827-47. PubMed ID: 8535981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.